A new study suggests that the antioxidant supplement mitoquinone, when combined with standard treatment, can improve heart health in patients with type 2 diabetes within four months. Individuals with type 2 diabetes face a significantly elevated risk of heart failure, up to five times higher than those without the condition, adn are more likely to experience mortality within five years following a heart failure diagnosis.

Researchers at the University of Liz University in the UK conducted a study involving 70 patients with type 2 diabetes but no pre-existing heart disease. The participants received standard treatment, with half also taking 40mg tablets of mitoquinone. heart scans were performed on all participants before the treatment and again after four months.

The group receiving Mitoquinone showed a 15% advancement in their ability to effectively manage and utilize energy. Furthermore, their heart muscles demonstrated improved relaxation speed, indicating a reversal of stress and stiffness indicators. Notably, there were no significant adverse heart-related symptoms, nor any major side effects attributed to mitoquinone intake. The control group showed no significant changes.

Expert commentary

“This result means that Mitoquinon keeps the heart of diabetics for a long time,”

according to Liz University’s lead author, Henry Procter, “This result means that Mitoquinon keeps the heart of diabetics for a long time.”

Diabetes disrupts the body’s ability to manage and use energy, leading to metabolic stress.This stress can damage heart muscle cells, causing stiffness and impaired blood pumping, ultimately leading to heart failure. Mitoquinone acts as an antioxidant, protecting cells from metabolic stress and subsequent damage.

The findings were recently presented at the British Cardiovascular Society meeting.